Pain in Cancer Patients
Conditions
Interventions
Four pads of the alternating magnetic field therapy device are placed on the area of pain for three days. The treatment time per day is set to 30, 60, or 120 minutes, depending on the time of registra
Sponsors
Kubo Emi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older on the day of consent acquisition 2. Cancer patients hospitalized in general wards/palliative care wards 3. No anti-cancer treatment is planned during the study period 4. Use of opioids equivalent to 50 mg/day of oral morphine or more 5. Able to express pain using the Numeric Rating Scale (NRS) and fill out a questionnaire in Japanese 6. Residual body pain of NRS2 or higher (regardless of cause) even after intervention by a palliative care physician 7. No active delirium (Confusion Assessment Methods negative) 8. Written informed consent to participate in the study of the participant's free will
Exclusion criteria
Exclusion criteria: 1. There is a skin disorder in the painful area where the lead is to be placed, making it impossible to place the lead. 2. There is a plan to change medication for pain. 3. Using life-sustaining medical electrical equipment such as a heart-lung machine or pacemaker or wearable medical electrical equipment such as an electrocardiogram. 4. Participating in clinical trials of other medicines or medical devices. 5. The doctor in charge judges that enrollment in this study is inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients who assessed they could continue the same treatment at home on Day 3 | — |
Contacts
Public ContactEmi Kubo
National Cancer Center Hospital East
Outcome results
None listed